/ no comments http://ift.tt/lW65Hn Article source: http://ift.tt/1ywdRkTSource:Novartis’ JUMP study reinforces safety, efficacy of Jakavi (ruxolitinib) for myelofibrosis treatment
No comments:
Post a Comment